HOMOCYSTEINE, ANTIPHOSPHOLIPID ANTIBODIES IN THE DEVELOPMENT OF SUBCLINICAL ATHEROSCLEROSIS IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS AND RHEUMATOID ARTHRITIS

Cardiovascular Risk ◽

Cardiovascular Risk Factors ◽

Lupus Erythematosus ◽

Systemic Lupus ◽

Comparable Effect

Hemorheological parameters are related to subclinical atherosclerosis in systemic lupus erythematosus and rheumatoid arthritis patients

Atherosclerosis ◽

10.1016/j.atherosclerosis.2011.08.026 ◽

2011 ◽

Vol 219 (2) ◽

pp. 821-826 ◽

Cited By ~ 33

Author(s):

Maria José Santos ◽

Luís Mendes Pedro ◽

Helena Canhão ◽

José Fernandes e Fernandes ◽

José Canas da Silva ◽

...

Keyword(s):

Rheumatoid Arthritis ◽

Lupus Erythematosus ◽

AB0048 Antiphospholipid antibodies, interleukin-6 and tumor necrosis factor-α in atherosclerotic process in patients with rheumatoid arthritis and systemic lupus erythematosus

10.1136/annrheumdis-2017-eular.5306 ◽

2017 ◽

Cited By ~ 1

Author(s):

NA Bashlakova ◽

TD Tyabut ◽

AE Buglova

Keyword(s):

Rheumatoid Arthritis ◽

Lupus Erythematosus ◽

Antiphospholipid Antibodies ◽

Tumor Necrosis ◽

Tumor Necrosis Factor Α ◽

Systemic Lupus ◽

Atherosclerotic Process ◽

Factor Α ◽

Necrosis Factor

Significance of antiphospholipid syndrome and antiphospholipid antibodies in patients with systemic lupus erythematosus in estimation of risk of subclinical atherosclerosis development

Polish Archives of Internal Medicine ◽

10.20452/pamw.256 ◽

2012 ◽

Vol 117 (Suppl. 1) ◽

pp. 13-17

Author(s):

Katarzyna Fischer ◽

Marek Brzosko ◽

Anna Walecka ◽

Lidia Ostanek ◽

Marcin Sawicki

Keyword(s):

Antiphospholipid Syndrome ◽

Lupus Erythematosus ◽

Antiphospholipid Antibodies ◽

Systemic Lupus ◽

Atherosclerosis Development ◽

Estimation Of Risk

Subclinical Atherosclerosis in Rheumatoid Arthritis and Systemic Lupus Erythematosus

The American Journal of Medicine ◽

10.1016/j.amjmed.2008.06.010 ◽

2008 ◽

Vol 121 (10) ◽

pp. S3-S8 ◽

Cited By ~ 151

Author(s):

Jane E. Salmon ◽

Mary J. Roman

Keyword(s):

Rheumatoid Arthritis ◽

Lupus Erythematosus ◽

Progression of subclinical atherosclerosis in systemic lupus erythematosus versus rheumatoid arthritis: the impact of low disease activity

Rheumatology ◽

10.1093/rheumatology/key233 ◽

2018 ◽

Vol 57 (12) ◽

pp. 2158-2166 ◽

Cited By ~ 6

Author(s):

Evrydiki Kravvariti ◽

George Konstantonis ◽

Petros P Sfikakis ◽

Maria G Tektonidou

Keyword(s):

Rheumatoid Arthritis ◽

Disease Activity ◽

Lupus Erythematosus ◽

Systemic Lupus ◽

Low Disease Activity ◽

The Impact

Subclinical atherosclerosis in Systemic Lupus Erythematosus: Comparable risk with Diabetes Mellitus and Rheumatoid Arthritis

Autoimmunity Reviews ◽

10.1016/j.autrev.2017.01.009 ◽

2017 ◽

Vol 16 (3) ◽

pp. 308-312 ◽

Cited By ~ 44

Author(s):

Maria G. Tektonidou ◽

Evrydiki Kravvariti ◽

George Konstantonis ◽

Nicholas Tentolouris ◽

Petros P. Sfikakis ◽

...

Keyword(s):

Rheumatoid Arthritis ◽

Diabetes Mellitus ◽

Lupus Erythematosus ◽

Faculty Opinions recommendation of Drug allergies may be more frequent in systemic lupus erythematosus than in rheumatoid arthritis.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.1120023.576146 ◽

2008 ◽

Author(s):

Andreas Bircher

Keyword(s):

Rheumatoid Arthritis ◽

Lupus Erythematosus ◽

Faculty Opinions recommendation of Novel therapies for immune-mediated inflammatory diseases: What can we learn from their use in rheumatoid arthritis, spondyloarthritis, systemic lupus erythematosus, psoriasis, Crohn's disease and ulcerative colitis?

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.727869572.793564281 ◽

2019 ◽

Author(s):

Ladislav Senolt

Keyword(s):

Rheumatoid Arthritis ◽

Ulcerative Colitis ◽

Crohn’S Disease ◽

Crohn's Disease ◽

Lupus Erythematosus ◽

Inflammatory Diseases ◽

Novel Therapies ◽

Systemic Lupus ◽

Immune Mediated

Interleukin-22 and Tumor Necrosis Factor Receptor Associated Factor 1 (TRAF1) in Patients with Rheumatoid Arthritis and Systemic Lupus Erythematosus: Correlation with Disease Activity

Egyptian Journal of Rheumatology and Clinical Immunology ◽

10.21608/ejrci.2015.4476 ◽

2015 ◽

Vol 3 (1) ◽

pp. 43-47

Author(s):

Eman Rashwan ◽

Mai Moaaz ◽

Nevine Mohannad ◽

Mohamed Rahman ◽

Eman Zaghloul

Keyword(s):

Rheumatoid Arthritis ◽

Tumor Necrosis Factor ◽

Disease Activity ◽

Lupus Erythematosus ◽

Tumor Necrosis ◽

Tumor Necrosis Factor Receptor ◽

Systemic Lupus ◽

Interleukin 22 ◽

Necrosis Factor